Acetazolamide

CAS 59-66-5 7 current records 4 historicalSmall Molecule

Who holds supplier records for Acetazolamide? 7 organisations hold a current record for Acetazolamide: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), Poland (1) and Australia (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Acetazolamide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/acetazolamide

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    5 of the 7 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Acetazolamide. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Acetazolamide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Acetazolamide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
EMCURE PHARMACEUTICALS LIMITED PuneIN
CEP 2018-203 - Rev 03
Acetazolamide
Mar 2026—
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Starogard GdanskiPL
CEP 2010-371 - Rev 03
Acetazolamide, Standard and milled
Mar 2026Inspected Jul 2026
Poland
NAKODA CHEMICALS LIMITED HyderabadIN
CEP 2001-387 - Rev 06
Acetazolamide
Jun 2025Inspected Jun 2023
France, outside 3-year window
CTX LIFESCIENCES PVT. LIMITED SuratIN
R1-CEP 2010-073 - Rev 03
Acetazolamide
Nov 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Acetazolamide are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • ESTEVE CDMO US INC
    Inactive DMF 22420 · filed Jan 2009
  • Italy · Inactive DMF 4647 · filed Aug 1982
  • CYANAMID GREAT BRITAIN LTD
    Inactive DMF 3443 · filed Feb 1979
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 2833 · filed Jan 1977

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Acetazolamide is a carbonic anhydrase inhibitor that is used to treat glaucoma, epilepsy, and altitude sickness. It reduces the formation of hydrogen and bicarbonate ions in the body, which decreases fluid pressure in the eyes and brain.

Chemical identity

IUPAC name
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
Canonical SMILES
CC(=O)NC1=NN=C(S1)S(=O)(=O)N
InChIKey
BZKPWHYZMXOIDC-UHFFFAOYSA-N
Synonyms
Diamox API, acetamox, acetazolamidum, atenezo, defiltran, diamox, didoc, diuriwas, donmox, edemox, glaupax, l 579486

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Carbonic Anhydrase Inhibitor
Mechanism of action
Carbonic Anhydrase Inhibitors
Chemical structure
Sulfonamides

Therapeutic areas

OphthalmologyNeurologyCardiology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Acetazolamide?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Acetazolamide: Emcure Pharmaceuticals Limited (India), NAKODA CHEMICALS LTD (India), Zakłady Farmaceutyczne Polpharma S.A. (Poland), CTX LIFE SCIENCES PVT LTD (India), GLAND PHARMA LTD (India), IDT AUSTRALIA LTD (Australia) and Ctx Lifesciences (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Acetazolamide Drug Master Files are active?

Emcure Pharmaceuticals Limited (DMF 20299), NAKODA CHEMICALS LTD (DMF 19763), Zakłady Farmaceutyczne Polpharma S.A. (DMF 10383), CTX LIFE SCIENCES PVT LTD (DMF 23014), GLAND PHARMA LTD (DMF 37616) and IDT AUSTRALIA LTD (DMF 12997). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Acetazolamide records mean?

4 organisations have only inactive Type II DMFs for Acetazolamide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Acetazolamide have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Acetazolamide on the EDQM register, including EMCURE PHARMACEUTICALS LIMITED Pune (IN), ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdanski (PL), NAKODA CHEMICALS LIMITED Hyderabad (IN) and CTX LIFESCIENCES PVT. LIMITED Surat (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Acetazolamide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Acetazolamide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.